Assessment of the sedative effects of buprenorphine administered with 10 μg/kg detomidine in horses.
Authors: Love E J, Taylor P M, Murrell J, Whay H R, Waterman-Pearson A E
Journal: The Veterinary record
Summary
# Editorial Summary Combining opioids with detomidine is common in equine practice for enhancing sedation, yet optimal dosing remains unclear. Love and colleagues conducted a randomised, observer-blinded crossover study in six horses to evaluate how buprenorphine at three doses (5, 7.5 and 10 µg/kg) compared with butorphanol (25 µg/kg) when combined with detomidine (10 µg/kg), measuring sedation depth, duration and overall effect using visual analogue scales and area-under-curve analysis. Whilst peak sedation and duration differed significantly between all treatments (P<0.001), the highest buprenorphine dose (10 µg/kg) produced a sedative effect statistically comparable to saline alone (P=0.051), suggesting a plateau in the dose–response relationship or possible paradoxical reduction in sedation at this concentration. For practitioners, these findings suggest that whilst lower buprenorphine doses (5–7.5 µg/kg) provide meaningful sedative augmentation with detomidine, escalating to 10 µg/kg offers no additional benefit and may warrant reconsideration in protocols where prolonged, predictable sedation is required.
Read the full abstract on PubMed
Practical Takeaways
- •Adding buprenorphine at 10 µg/kg to detomidine 10 µg/kg does not enhance sedation compared to detomidine alone, suggesting this combination may not provide additional clinical sedative benefit
- •Lower buprenorphine doses (5-7.5 µg/kg) with detomidine produce measurably different sedation profiles and may be worth evaluating for specific clinical applications
- •Detomidine-buprenorphine combinations require dose optimization; not all combinations improve the sedative effect
Key Findings
- •Peak sedation and duration of sedation differed significantly between all six treatment groups (P<0.001)
- •Detomidine 10 µg/kg with 10 µg/kg buprenorphine (D/B10) produced sedation levels not significantly different from saline control (P=0.051)
- •Detomidine alone and detomidine combined with lower buprenorphine doses (5-7.5 µg/kg) or butorphanol produced significantly greater sedation area under curve than saline control